Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
Clinical trial NCT03794336 · COMPLETED
Trial details
- NCT number
- NCT03794336
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-29
- Primary completion
- 2020-12-14
- Enrollment
- 1293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.